FDA guidance on foods derived from gene-edited plants ‘doubles down’ on view that safety hinges on the final product, not the production method
Long-awaited guidance from FDA on the safety of foods derived from gene-edited plants reiterates the agency’s position that biotechnology is not inherently unsafe, but still encourages developers to voluntarily engage with the agency before going to market to ensure the food meets the same safety requirements as those from traditionally bred plants.